BP11085 PCL, poly(ε-caprolactone), Hydroxyl Terminated, IV: 1.0–1.5 dl/g, Mw: 112–198 kDa

PCL, poly(ε-caprolactone), Hydroxyl Terminated, IV: 1.0–1.5 dl/g, Mw: 112–198 kDa Description

PCL, poly(ε-caprolactone) is a semicrystalline, aliphatic polymer known for its biodegradability and processability. The hydroxyl termination facilitates further chemical derivatization, which is essential for applications requiring polymer blending or functionalisation. The specified intrinsic viscosity (IV) and molecular weight (Mw) parameters contribute to determining the polymer's mechanical and degradation properties in biomedical and research settings.

PCL, poly(ε-caprolactone), Hydroxyl Terminated, IV: 1.0–1.5 dl/g, Mw: 112–198 kDa Applications

1.         Healthcare and Biomedical Research
- Use as a scaffold material in tissue engineering to achieve controlled degradation by leveraging its predictable hydrolysis behaviour.
- Applied as a drug delivery matrix in controlled release systems to manage dosage rates by leveraging hydroxyl group functionality.

2.         Advanced Biofabrication and Material Studies
- Used as a mouldable polymer in laboratory synthesis of biocompatible composites to achieve desired mechanical integrity by leveraging its controlled molecular weight and viscosity.

PCL, poly(ε-caprolactone), Hydroxyl Terminated, IV: 1.0–1.5 dl/g, Mw: 112–198 kDa Packing

The material is packaged in sealed, moisture-resistant barrier pouches accompanied by desiccants to reduce oxygen and humidity exposure. The packaging is engineered to limit contamination and physical stress during transport and storage. It is recommended to store the material in a cool, dry environment away from direct light. Custom packaging options and labelling modifications are available to accommodate specific laboratory or production requirements.

Additional Information

PCL is a biodegradable polyester extensively studied in the field of biocompatible materials. Its controlled degradation and ease of processing make it a valuable material for biomedical applications such as tissue scaffolding and drug delivery systems. Understanding the relationship between molecular weight and intrinsic viscosity is critical for tailoring its performance.

The hydroxyl termination enhances the polymer's hydrophilicity and provides active sites for chemical functionalisation, improving its compatibility with hydrophilic matrices and facilitating covalent bonding in composite systems. This expands its utility in advanced manufacturing and bioactive material design. Ongoing research continues to refine processing techniques to optimise performance and reliability across diverse applications.

Regulatory Note: This material is designed for industrial and consumer applications. It is the customer's responsibility to ensure compliance with all applicable safety and regulatory requirements for their intended use.